Clinical Trial Update: Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD [Phase 3]

View source ↗

Summary

Phase 3 trial update assessing safety and efficacy of inhaled insulin in patients with diabetes and asthma or COPD.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease
• Diabetes Mellitus

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Asthma | Phase 3 | Status: COMPLETED